BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

367 related articles for article (PubMed ID: 12685114)

  • 1. [Renal lithiasis due to indinavir].
    Fernández JM; Robles JE; Regojo JM; López J; Sánchez D; Arocena J; Rosell D; Zudaire JJ; Berián JM
    Rev Med Univ Navarra; 2002; 46(3):28-32. PubMed ID: 12685114
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Indinavir urolithiasis.
    Wu DS; Stoller ML
    Curr Opin Urol; 2000 Nov; 10(6):557-61. PubMed ID: 11148725
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Protease inhibitor-induced urolithiasis.
    Gentle DL; Stoller ML; Jarrett TW; Ward JF; Geib KS; Wood AF
    Urology; 1997 Oct; 50(4):508-11. PubMed ID: 9338723
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Urolithiasis associated with the protease inhibitor indinavir.
    Bruce RG; Munch LC; Hoven AD; Jerauld RS; Greenburg R; Porter WH; Rutter PW
    Urology; 1997 Oct; 50(4):513-8. PubMed ID: 9338724
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Urolithiasis associated with protease inhibitors.
    Sundaram CP; Saltzman B
    J Endourol; 1999 May; 13(4):309-12. PubMed ID: 10405912
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Urinary lithiasis secondary to indinavir in an HIV-positive patient].
    Moyano Calvo JL; Huesa Martínez I; Cruz Navarro N; Leal Arenas J; León Dueñas E; Morales López A; Maestro Durán JL; Ramírez Mendoza A
    Arch Esp Urol; 2001 Dec; 54(10):1117-20. PubMed ID: 11852520
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Ureteral obstruction secondary to indinavir in the pediatric HIV population.
    Noble CB; Klein LT; Staiman VR; Neu N; Hensle TW; Berdon WE
    Pediatr Radiol; 1998 Aug; 28(8):627-9. PubMed ID: 9716639
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Crystalluria and urinary tract abnormalities associated with indinavir.
    Clayman RV
    J Urol; 1998 Aug; 160(2):633. PubMed ID: 9679944
    [No Abstract]   [Full Text] [Related]  

  • 9. Nephrolithiasis on indinavir.
    Prescrire Int; 1999 Feb; 8(39):22. PubMed ID: 10557573
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Crystalluria and nephrolithiasis during therapy with the protease inhibitor indinavir].
    Rickerts V; Kober A; Stille W
    Dtsch Med Wochenschr; 1997 Jun; 122(24):803. PubMed ID: 9229567
    [No Abstract]   [Full Text] [Related]  

  • 11. Indinavir urolithiasis: an emerging cause of renal colic in patients with human immunodeficiency virus.
    Kohan AD; Armenakas NA; Fracchia JA
    J Urol; 1999 Jun; 161(6):1765-8. PubMed ID: 10332431
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Symptomatic crystalluria associated with indinavir.
    Famularo G; Di Toro S; Moretti S; De Simone C
    Ann Pharmacother; 2000 Dec; 34(12):1414-8. PubMed ID: 11144699
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Indinavir crystalluria: identification of patients at increased risk of developing nephrotoxicity.
    Trainor LD; Steinberg JP; Austin GW; Solomon HM
    Arch Pathol Lab Med; 1998 Mar; 122(3):256-9. PubMed ID: 9823864
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Indinavir crystallization and urolithiasis.
    Grases F; Costa-Bauzá A; García-González R; Payeras A; Bassa A; Torres JJ; Conte A
    Int Urol Nephrol; 1999; 31(1):23-9. PubMed ID: 10408298
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Acute renal failure due to indinavir crystalluria and nephrolithiasis: report of two cases.
    Berns JS; Cohen RM; Silverman M; Turner J
    Am J Kidney Dis; 1997 Oct; 30(4):558-60. PubMed ID: 9328372
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Nephritic colic due to indinavir].
    Hermieu JF; Prévot MH; Ravery V; Moulinier F; Delmas V; Bouvet E; Boccon-Gibod L
    Presse Med; 1998 Mar; 27(10):465-7. PubMed ID: 9767973
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Increased prevalence and analysis of risk factors for indinavir nephrolithiasis.
    Saltel E; Angel JB; Futter NG; Walsh WG; O'Rourke K; Mahoney JE
    J Urol; 2000 Dec; 164(6):1895-7. PubMed ID: 11061951
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Nonopaque crystal deposition causing ureteric obstruction in patients with HIV undergoing indinavir therapy.
    Blake SP; McNicholas MM; Raptopoulos V
    AJR Am J Roentgenol; 1998 Sep; 171(3):717-20. PubMed ID: 9725303
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Renal toxicity of protease inhibitors.
    Olyaei AJ; deMattos AM; Bennett WM
    Curr Opin Nephrol Hypertens; 2000 Sep; 9(5):473-6. PubMed ID: 10990364
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Urolithiasis associated with indinavir in a patient with spinal cord injury.
    Yudkoff BL; Linsenmeyer TA; Oakley A; Kirshblum S
    J Spinal Cord Med; 2004; 27(3):263-5. PubMed ID: 15478531
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.